Recommended Screening and Preventive Practices for Long-Term Survivors after Hematopoietic Cell Transplantation

Navneet S. Majhail(National Marrow Donor Program), J. Douglas Rizzo, Stephanie J. Lee(Fred Hutch Cancer Center), Mahmoud Aljurf(King Faisal Specialist Hospital & Research Centre), Yoshiko Atsuta(Nagoya University), Carmem Bonfim(Universidade Federal do Paraná), Linda J. Burns(University of Minnesota System), Naeem Chaudhri(King Faisal Specialist Hospital & Research Centre), Stella M. Davies(Cincinnati Children's Hospital Medical Center), Shinichiro Okamoto(Keio University), Adriana Seber(Support group for adolescents and children with cancer), Gèrard Socié(Hôpital Saint-Louis), Jeff Szer(The Royal Melbourne Hospital), Maria Teresa Van Lint(Ospedale Policlinico San Martino), John R. Wingard(University of Florida), André Tichelli(University Hospital of Basel)
Biology of Blood and Marrow Transplantation
December 13, 2011
10.1016/j.bbmt.2011.12.519
Cited by 363

Abstract

Related Papers

Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study
Ravi Bhatia, Liton Francisco, Andrea Carter et al.|Blood|2007|536
Guidelines for preventing infectious complications among hematopoietic cell transplant recipients: a global perspective
Marcie Tomblyn, Tom Chiller, Hermann Einsele et al.|Bone Marrow Transplantation|2009|384
Vaccination of hematopoietic cell transplant recipients
Per Ljungman, Catherine Cordonnier, Hermann Einsele et al.|Bone Marrow Transplantation|2009|319
Secondary solid cancers after allogeneic hematopoietic cell transplantation using busulfan-cyclophosphamide conditioning
Navneet S. Majhail, Ruta Brazauskas, J. Douglas Rizzo et al.|Blood|2010|221
Prospective evaluation of neurological complications after allogeneic bone marrow transplantation
P. Sostak, C. S. Padovan, Tarek A Yousry et al.|Neurology|2003|180